Index of artpub/2023/289522/

Martin, Thomas G
Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma : Results From the Phase II MajesTEC-1 Study
2023
https://ddd.uab.cat/record/289522